Northwest Biotherapeutics Inc. | Finanzwire

Basculer en Français

10466	Companies
220191	Keywords
149520	Articles
116417	Press releases

Headlines Articles Press releases Northwest Biotherapeutics Inc.

Home
Companies
Northwest Biotherapeutics Inc.

BRIEF

published on 05/28/2026 at 13:48, 2 hours 7 minutes ago

Northwest Biotherapeutics Receives "Buy" Rating Despite Modest Financial Performance

Buy Recommendation Northwest Biotherapeutics FY/25 Results DCVax-L Launch MHRA Decision
PRESS RELEASE

published on 05/28/2026 at 13:43, 2 hours 12 minutes ago

Original-Research: Northwest Biotherapeutics Inc. (von First Berlin Equity Research GmbH): BUY
First Berlin Equity Research updates BUY rating for Northwest Biotherapeutics Inc. with USD 1.00 target price. FY/25 results exceeded estimates, focusing on operational improvements and regulatory milestones

Operational Improvements BUY Rating Northwest Biotherapeutics Inc. FY/25 Results USD 1.00 Target Price
BRIEF

published on 03/24/2026 at 16:06, 2 months 3 days ago

Northwest Biotherapeutics Gains Positive Outlook with Innovative Therapy

Regulatory Approval Glioblastoma Treatment Northwest Biotherapeutics DCVax-L Therapy Oncology Innovations
PRESS RELEASE

published on 03/24/2026 at 16:01, 2 months 3 days ago

Original-Research: Northwest Biotherapeutics Inc. (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research initiates coverage on Northwest Biotherapeutics Inc., with a Buy rating and USD 1.00 price target. Company is developing DCVax-L for glioblastoma

First Berlin Equity Research BUY Rating Coverage Northwest Biotherapeutics Inc. DCVax-L

Accesswire

Published on 05/28/2026 at 15:40, 15 minutes ago

Galantas Gold Completes $100 Million Private Placement
Published on 05/28/2026 at 15:20, 35 minutes ago

Formation Metals Inc. Provides Corporate Update Following C$22.4 Million Financing, Announces Participation in The Mining Investment Event, and Hosts Live CEO Investor Webinar
Published on 05/28/2026 at 15:00, 55 minutes ago

INEO Announces Upsizing of Previously Announced Private Placement Financing
Published on 05/28/2026 at 14:30, 1 hour 25 minutes ago

AIAI Holdings' Constellation Network Unveils Gate AI Security Gateway and Performance Benchmarks Ahead of June Launch
Published on 05/28/2026 at 13:30, 2 hours 25 minutes ago

ROK Resources Files Financial Results and Management Discussion & Analysis for First Quarter of 2026

View all ACCESSWIRE

EQS Group

Published on 05/28/2026 at 15:35, 20 minutes ago

Haier Biomedical Achieves Double No. 1 Ranking in Euromonitor's Global Life Science Lab Equipment Report, Caps Three-Phase Global Expansion
Published on 05/28/2026 at 15:23, 31 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
Published on 05/28/2026 at 15:22, 32 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
Published on 05/28/2026 at 15:21, 33 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Senior plc
Published on 05/28/2026 at 15:20, 34 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Schroders plc

Les Echos

Published on 05/28/2026 at 10:30, 5 hours 25 minutes ago

Recticel Group included in Top 100 Financial Times list of Europe’s Climate Leaders
Published on 05/28/2026 at 08:45, 7 hours 10 minutes ago

Appointment of Mikael Frenkian as Chief Executive Officer of Baikowski
Published on 05/27/2026 at 23:00, 16 hours 55 minutes ago

BIOPHYTIS CHANGES ITS FINANCING AGREEMENT WITH HEXAGON CAPITAL FUND TO ENSURE ITS €2 MILLION FACILITY IS RENEWABLE
Published on 05/27/2026 at 20:28, 19 hours 26 minutes ago

Combined Shareholders’ Meeting of May 27, 2026
Published on 05/27/2026 at 17:45, 22 hours 10 minutes ago

Imerys-05-2026-information-share-capital-and-voting-rights-as-of-30-April-2026

View all LES ECHOS COMFI WIRE